The tragic trajectory of Jim Irsay's struggle with addiction has cast a shadow across the sports and medical communities, bringing to light the complexities of opioid dependency and the pressures surrounding public figures in recovery. Recent reports by WTHR indicate concerns were raised over prescriptions filled out for the late Indianapolis Colts owner, including opioid pills like hydrocodone and oxycodone. These medications are typically not considered first-line treatments for addiction, yet according to the National Institutes of Health, a staggering 16 million individuals worldwide suffer from opioid use disorder, with 2.1 million of those cases in the United States alone.
Further details gathered by WISH-TV report a narrative of concealment and concern within the Colts organization. Allegations suggest the team may have attempted to quietly manage Irsay's relapses, including one in March 2023 following a shoulder surgery which led to a new round of pain pill prescriptions. Dr. Harry Haroutunian, a physician with ties to premier addiction treatment programs, is said to have prescribed Irsay large doses of opioids and went as far to administer ketamine injections up to 14 times daily, starting in the same year.
The saga has prompted uncomfortable conversations about public perception and the stark realities of addiction. A piece by Gregg Doyel for the IndyStar, reflects on Irsay's decade-long announcement of being in recovery.
The late Colts owner's death has provoked queries regarding the extent to which society should be privy to the personal health struggles of high-profile individuals. Doyel notes that the public often chooses to hear "what we wanted, that he was OK, that the longtime owner of the Indianapolis Colts was a recovering addict, emphasis on recovering."
.jpg){kind=link}